Take a look at some of Monday's morning movers:
Amylin Pharmaceuticals - Bristol-Myers Squibb is buying Amylin for $31 per share, or $5.3 billion in cash . In a follow-on deal, AstraZeneca will pay Bristol-Myers $3.4 billion for the right to collaborate on developing Amylin drugs after the deal is complete.
Lincare Holdings - Lincare is being bought by Germany’s Linde for $4.6 billion in cash . Lincare is a specialist in home-based oxygen therapy, while Linde is a maker of industrial gases.
Ingram Micro - The technology distributor is buying wireless device company BrightPoint for $650 million in cash. Ingram is seeking to expand into the mobile market, which has higher profit margins than its core personal computer business.
Barclays - Chairman Marcus Agius has resigned , in the wake of the Libor probe into interest-rate fixing that resulted in Barclays paying more than $450 million in fines. Chief Executive Officer Bob Diamond is also said to be under pressure to resign, but has not done so.
Apple - The company is paying $60 million to China’s ProView Technology to settle a trademark dispute over the iPad name.Page 1 of 3 | Next Page